Joseph P. Lucia & Associates, LLC Editas Medicine, Inc. Transaction History

Joseph P. Lucia & Associates, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 04, 2022	SELL	$26.55 - $40.57 $1,008 - $1,541	-38 Closed	0 $0
Q2 2021 Jul 27, 2021	SELL	$31.29 - $56.64 $6,258 - $11,328	-200 Reduced 84.03%	38 $2,000
Q4 2020 Jan 29, 2021	BUY	$27.07 - $84.35 $6,442 - $20,075	238 New	238 $17,000
Q3 2020 Oct 20, 2020	SELL	$28.06 - $37.16 $10,241 - $13,563	-365 Closed	0 $0
Q2 2020 Jul 10, 2020	BUY	$18.5 - $34.34 $5,550 - $10,302	300 Added 461.54%	365 $11,000
Q2 2019 Jul 23, 2019	SELL	$20.48 - $27.76 $34,918 - $47,330	-1,705 Reduced 96.33%	65 $2,000
Q1 2019 May 02, 2019	BUY	$19.43 - $26.41 $34,391 - $46,745	1,770 New	1,770 $65,000

248

57M

410K

394K

Ticker EDIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,737,200
Market Cap $85.9M
Description
Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...

Get notified when there are updates to the investment portfolio of Joseph P. Lucia & Associates, LLC, based on Form 13F filings with the SEC.

Stay updated on Joseph P. Lucia & Associates, LLC with notifications on news.